iShares Nasdaq Profile

The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. iShares Nasdaq is traded on NASDAQ General Markets in USA. more
NameiShares Nasdaq Biotechnology ETF
ChairmanGeorge ParkerView All
Macroaxis Advice
InstrumentUSA Etf View All
RegionNorth America
Investment IssuerBlackrock
ExchangeNASDAQ General Markets
Etf FamilyBlackrock
Fund CategorySector
Portfolio ConcentrationHealth Care
BenchmarkDOW
Phone800 474 2737
CurrencyUSD - US Dollar
IssuerBlackrock
DescriptioniShares Nasdaq Biotechnology ETF
Inception Date2001-02-05
BenchmarkNASDAQ Biotechnology TR USD
Entity TypeRegulated Investment Company
Asset Under Management9.68 Billion
Average Trading Valume2.7 Million
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Portfolio ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
Transfer AgentState Street Bank and Trust Company
Fiscal Year EndMarch 31
ExchangeThe NASDAQ Stock Market LLC
Number of Constituents194
Market MakerVirtu Financial
Total Expense0.47
Management Fee0.47
Please also check Risk vs Return Analysis. Please also try Chance of Distress module to get analysis of equity chance of financial distress in the next 2 years.